Scott Thomas Hollenbeck

Scott Thomas Hollenbeck

Auto-generated profile, based on publicly available information

Scott Thomas Hollenbeck

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, North Carolina

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2021 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
PDF file
RSRonnie L. Shammas
Ronnie L. Shammas
CMCaitlin E. Marks
Caitlin E. Marks
GBGloria Broadwater
Gloria Broadwater
ELElliot Le
Elliot Le
AGAdam D. Glener
Adam D. Glener
SHScott T. Hollenbeck
Scott T. Hollenbeck
Background Psychosocial distress, depression, or anxiety can occur in up to 50% of women after a breast cancer diagnosis and mastectomy. The purpose of this study was to assess the potential benefit of lavender oil as a perioperative adjunct to improve anxiety, depression, pain, and sleep in women undergoing microvascular breast reconstruction.Methods This was a prospective, single-blinded, randomized, controlled trial of 49 patients undergoing microvascular breast reconstruction. Patients were randomized to receive lavender oil or placebo (coconut oil) throughout their hospitalization. The effect of lavender oil on perioperative stress, anxiety, depression, sleep, and pain was measured using the hospital anxiety and depression scale, Richards–Campbell Sleep Questionnaire, and the visual analogue scale.Results Twenty-seven patients were assigned to the lavender group and 22 patients were assigned to the control group. No significant differences were seen in the perioperative setting between the groups with regard to anxiety (p = 0.82), depression (p = 0.21), sleep (p = 0.86), or pain (p = 0.30) scores. No adverse events (i.e., allergic reaction) were captured, and no significant differences in surgery-related complications were observed. When evaluating the entire cohort, postoperative anxiety scores were significantly lower than preoperative scores (p < 0.001), while depression scores were significantly higher postoperatively as compared with preoperatively (p = 0.005).Conclusion In the setting of microvascular breast reconstruction, lavender oil and aromatherapy had no significant adverse events or complications; however, there were no measurable advantages pertaining to metrics of depression, anxiety, sleep, or pain as compared with the control group.

31 August 2015 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
PDF file
ECEugenia H. Cho
Eugenia H. Cho
RGRyan M. Garcia
Ryan M. Garcia
JBJared Blau
Jared Blau
HLHoward Levinson
Howard Levinson
DEDetlev Erdmann
Detlev Erdmann
SHScott T. Hollenbeck
Scott T. Hollenbeck
Background The decision to perform an end-to-end (ETE) or end-to-side (ETS) arterial anastomosis in lower extremity free tissue transfer has not been thoroughly evaluated in a large multisurgeon setting. The authors compared the reconstructive outcomes of lower extremity free flaps with ETE and ETS arterial anastomoses. Methods The authors retrospectively reviewed their 17-year institutional experience with lower extremity free flaps to determine whether ETE or ETS arterial anastomoses were associated with foot ischemic complications and flap failure. Results From 1996 to 2013, 398 patients underwent 413 lower extremity free flaps with ETE (66%) or ETS (34%) arterial anastomoses. The incidence of postoperative foot ischemia was 2% (n = 8). The flap failure rate was 11% (n = 45). The ETS technique was preferred in patients with fewer intact vessels to the foot (32% ETS for three-vessel runoff, 36% ETS for two-vessel runoff, and 50% ETS for single-vessel runoff) and when an intact recipient vessel was selected for anastomosis (60% ETS for intact vessel vs. 25% ETS for distally occluded vessel). No differences were observed in the foot ischemia (p = 0.45) and flap failure rates (p = 0.59) for ETE versus ETS arterial anastomoses. In subset analyses, the incidence of foot ischemia did not differ for either technique in the context of impaired vascular runoff or recipient vessel selection. Conclusion No advantage was noted for ETE or ETS arterial anastomoses based on reconstructive outcomes. The choice of anastomotic technique in lower extremity free tissue transfer should be based on patient factors and the clinical circumstances encountered.

1 May 2016 in Annals of Plastic Surgery
Verified
Journal Article
Closed access
IPIrene Bs Pien
Irene Bs Pien
SCSophia Bs Caccavale
Sophia Bs Caccavale
MCMichael C. Cheung
Michael C. Cheung
PBParag Butala
Parag Butala
DHDuncan B. Hughes
Duncan B. Hughes
SHScott T. Hollenbeck
Scott T. Hollenbeck
Background Enthusiasm for the deep inferior epigastric artery perforator (DIEP) flap for autologous breast reconstruction has grown in recent years. However, this flap is not performed at all centers or by all plastic surgeons for breast reconstruction, and it is unclear whether practice patterns have measurably changed. This study aimed to (1) evaluate changing trends in breast flap use in the United States in recent years and (2) identify how these trends have affected charges and costs associated with autologous breast reconstruction. Methods Patients undergoing autologous breast reconstruction [latissimus dorsi (LD), pedicled transverse rectus abdominus myocutaneous (pTRAM), free TRAM (fTRAM), and DIEP] were identified using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database (2009-2011). A total of 19,182 hospital discharges were reviewed. Patient demographics, hospital teaching center status, payer status, length of stay, total charges, and total costs per discharge were reviewed. Statistical analysis was performed using linear regression, t test, and analysis of variance models. Results Between 2009 and 2011, the total number of discharges did not change significantly. Patient age distribution was similar for all flap groups. For individual flaps, there was a significant increase in DIEP flaps (P = 0.03), with a decreasing trend for other abdominal-based flaps. The patients receiving DIEP flap breast reconstruction were covered by private insurance at a higher rate than all other flap procedures (P = 0.03), whereas other potential cost determinants did not differ significantly between the groups. The mean charge per flap was $40,704 for LD, $51,933 for pTRAM, $69,909 for fTRAM, and $82,320 for DIEP. The mean cost per flap was $12,017 for LD, $15,538 for pTRAM, $20,756 for fTRAM, and $23,616 for DIEP. Conclusions Between 2009 and 2011, the total amount of autologous breast reconstruction discharges was relatively stable, but the number of DIEP flaps increased significantly. Review of the Healthcare Cost and Utilization Project Nationwide Inpatient Sample data shows that, compared with LD, pTRAM, and fTRAM flaps, the DIEP flap is associated with higher charges and costs.

1 April 2019 in Journal of Surgical Research
Verified
Journal Article
Closed access
ASAmanda R. Sergesketter
Amanda R. Sergesketter
DLDavid T. Lubkin
David T. Lubkin
RSRonnie L. Shammas
Ronnie L. Shammas
KKKate B. Krucoff
Kate B. Krucoff
SPSarah B. Peskoe
Sarah B. Peskoe
SHScott T. Hollenbeck
Scott T. Hollenbeck

28 February 2014 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
PDF file
ECEugenia H. Cho
Eugenia H. Cho
RGRyan Garcia
Ryan Garcia
IPIrene Pien
Irene Pien
STSteven Thomas
Steven Thomas
SLScott L. Levin
Scott L. Levin
SHScott T. Hollenbeck
Scott T. Hollenbeck
Wound breakdown after orthopaedic foot and ankle surgery may necessitate secondary soft tissue coverage. The foot and ankle region is challenging to reconstruct for orthopaedic and plastic surgeons owing to its complex bony anatomy and unique functional demands. Therefore, identifying strategies for plastic surgery of these wounds may help guide surgeons in defining the best treatment plan.

15 September 2022 in Plastic and Reconstructive Surgery
Verified
Journal Article
Open access
MTMahsa Bs Taskindoust
Mahsa Bs Taskindoust
TBTrevor Ged Bowman
Trevor Ged Bowman
STSamantha M Thomas
Samantha M Thomas
HLHeather Levites
Heather Levites
VWVictoria Wickenheisser
Victoria Wickenheisser
SHScott T. Hollenbeck
Scott T. Hollenbeck
Background: There is growing recognition of a condition known as breast implant illness. Very little information exists about the diagnosis and natural history of breast implant illness. To better understand the patient experience, we surveyed the U.S. Food and Drug Administration’s Manufacturer and User Facility Device Experience (MAUDE) database for narratives describing symptoms of breast implant illness. Methods: The MAUDE database was queried for all reports that included breast implant illness within the patient narrative between 2010 and 2020. A review of narratives was used to identify and summarize 36 symptoms over nine symptom classes. Event year and reporting year were summarized. Hierarchical clustering analysis using centroid components was conducted on all reported breast implant illness symptoms, and a dendrogram was created to visualize clustering. Results: During the study period from 2010 to 2020, there were 751 captured adverse event reports in the MAUDE database that referenced breast implant illness, with the first report submission in 2014. Of those reports, 60.6 percent were for silicone implants and 39.4 percent were for saline implants. The three most commonly reported symptom categories were neurologic [n = 544 (72.4 percent)], followed by musculoskeletal [n = 418 (55.7 percent)], and dermatologic [n = 273 (36.4 percent)]. The top 10 symptoms, irrespective of category, include fatigue/weakness, numbness/tingling, brain fog, depression/anxiety, arthralgia, myalgia, headache, hair loss, gastrointestinal issues, and weight change. A hierarchical clustering analysis demonstrated that symptoms reported by patients clustered into two major groups. Conclusion: This study demonstrates the utility of public-facing databases, such as the Manufacturer and User Facility Device Experience database, in understanding the patient experience as it relates to breast implant illness.